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Research Article
Gender Differences in Effectiveness of the Complete Health
Improvement Program (CHIP)
Lillian M. Kent, PhD1; Darren P. Morton, PhD1; Paul M. Rankin, PhD1;
John E. Gobble, DrPH2; Hans A. Diehl, DrHSc3
ABSTRACT
Objective: To determine the differential effect of gender on outcomes of the Complete Health Improve-
ment Program, a chronic disease lifestyle intervention program.
Design: Thirty-day cohort study.
Setting: One hundred thirty-six venues around North America, 2006 to 2009.
Participants: A total of 5,046 participants (33.5% men, aged 57.9  13.0 years; 66.5% women, aged
57.0  12.9 years).
Intervention: Diet, exercise, and stress management.
MainOutcomeMeasures: Bodymass index, diastolic blood pressure, systolic blood pressure, lipids, and
fasting plasma glucose (FPG).
Analysis: The researchers used t test and McNemar chi-square test of proportions, at P < .05.
Results: Reductions were significantly greater for women for high-density lipoprotein (9.1% vs 7.6%)
but greater for men for low-density lipoprotein cholesterol (16.3% vs 11.5%), total cholesterol (TC)
(13.2% vs 10.1%), triglycerides (11.4% vs 5.6%), FPG (8.2% vs 5.3%), body mass index (3.5% vs 3%),
diastolic blood pressure (5.5% vs 5.1%), and TC/high-density lipoprotein (6.3% vs 1.4%) but not different
for systolic blood pressure (6% vs 5%). The greatest reductions were in participants with the highest base-
line TC, low-density lipoprotein, triglycerides, and FPG classifications.
Conclusions and Implications: TheCompleteHealth ImprovementProgrameffectively reduced chronic
disease risk factors amongboth genders, but particularlymen,with the largest reductions occurring in individ-
uals at greatest risk. Physiological or behavioral factor explanations, including differences in adiposity and
hormones, dietary intake, commitment and social support, are explored. Researchers should consider
addressing gender differences in food preferences and eliciting commitment and differential support modes
in the development of lifestyle interventions such as the Complete Health Improvement Program.
KeyWords: chronic disease, health behavior, risk factors, men, women (J Nutr Educ Behav. 2015;47:44-52.)
Accepted August 31, 2014. Published online October 11, 2014.
INTRODUCTION
Chronic diseases are the leading
causes of death and disability in the
US, with more than half of all deaths
each year attributed to heart disease,
stroke, diabetes, and cancer.1 Chronic
diseases carry a major fiscal burden.
The direct (medical) and indirect (pro-
ductivity) costs of cardiovascular dis-
ease alone are projected to increase
from $450 billion in 2010 to more
than $1 trillion by 2030.2
Lifestyle modification programs
have been shown to be effective in
the treatment of chronic disease.3
The Complete Health Improvement
Program (CHIP) is a lifestyle modifica-
tion program that is delivered by
either health professionals or trained
volunteers in various workplaces and
community and medical settings.4-7
Underpinning the CHIP intervention
is the Theory of Planned Behavior,
which asserts that behavior is driven
by intentions that are in turn formed
by attitudes, social norms, and
perceived control.8 The Complete
Health Improvement Program in-
cludes a strong educative component
to change participants' attitudes to-
ward healthy living, group support
to help foster social norms that pro-
mote a healthy lifestyle, and regular
health risk assessments to increase
participants' health-related self-effi-
cacy and perceived control.
The Complete Health Improve-
ment Program has been demonstrated
to achieve meaningful reductions in
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selected risk factors—bodymass index
(BMI), blood pressure (BP), total
cholesterol (TC), low-density lipopro-
tein (LDL), triglycerides (TG), and
fasting plasma glucose (FPG)—for car-
diovascular disease and type 2 dia-
betes mellitus among large cohorts
from several countries including the
US.4-7 Furthermore, the reduction in
risk factors and self-reported adher-
ence to the health behaviors pro-
moted in CHIP have been found to
occur over the long-term, which indi-
cates that CHIP is a useful intervention
for enabling behavior change.9,10 A
detailed analyses of the differential
responsiveness of males and females
to the CHIP intervention has not
been performed. Differences in the
responsiveness of men and women
might be expected because gender
differences exist in a number of
health outcomes and have been
attributed to hormonal, behavioral,
social and/or psychological factors.11-15
The aim of the current study was to
examine differences in the short-term
responsiveness of men and women to
the CHIP intervention, as measured
by changes in selected chronic disease
risk factors.
METHODS
Study Participants
The CHIP intervention, which was
previously described in detail,4-7 was
delivered to 5,046 participants who
had self-selected to participate in the
program between January, 2006 and
October, 2009. A total of 176 CHIP
interventions (mean group size, 29;
range, 3228) were conducted at 136
venues throughout North America
over this period. There were no inclu-
sion or exclusion criteria other than
the participant being able to pay a
$200 program cost. By comparison,
weight loss diets typically cost more
than this per annum.16 Participants
were invited to attend the interven-
tion through word of mouth invita-
tion, local media avenues, and
referrals from health care providers.
As indicated by baseline characteris-
tics (Tables 1 and 2), participants
comprised a more at-risk and ill
demographic compared with the
general North American popula-
tion.17,18 The Avondale College of
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Table 2. Changes in Risk Factor Levels Within 30 Days, by Gender and Initial Risk Factor Classification, North America, 20062009
Risk Factor
Men Women
Baseline,
n (%)a
30 d,
N (%)a,b
Baseline
(mean ± SD)
30 d
(mean ± SD)c
Mean Change
(95% confidence
interval) (%)
Baseline,
n (%)a 30 d, N (%)a,b
Baseline
(mean ± SD)
30 d
(mean ± SD)c
Mean Change
(95% confidence
interval) (%)
Body mass
index, kg/m2
c2 ¼ 187.71, P < .001 c2 ¼ 300.53, P < .001
< 18.5 9 (0.6) 9 (0.6) 17.5  1.1 17.4  0.9 0.1 (0.5, 0.3) (0.4) 18 (0.6) 23 (0.8) 17.6  0.8 17.5  0.7 0.2 (0.4, 0.1) (1.0)
18.524.9 230 (14.9) 317 (20.6) 23.2  1.4 22.7  1.3 0.5 (0.5, 0.4)* (2.0) 641 (21.6) 777 (26.1) 22.6  1.7 22.0  1.6 0.5 (0.6, 0.5)* (2.3)
25–29.9 547 (35.5) 570 (37.0) 27.5  1.4 26.6  1.5 1.0 (1.0, 0.9)* (3.4) 841 (28.3) 867 (29.2) 27.4  1.4 26.6  1.5 0.8 (0.9, 0.8)* (3.0)d
$ 30 754 (49.0) 644 (41.8) 36.2  5.9 34.8  5.6 1.4 (1.5, 1.3)* (3.8) 1,472 (49.5) 1,305 (43.9) 36.9  6.2 35.7  6.1 1.2 (1.2, 1.1)** (3.2)d
Systolic blood
pressure,
mm Hg
c2 ¼ 267.33, P < .001 c2 ¼ 387.43, P < .001
< 120 261 (16.9) 409 (26.5) 110.8  6.3 115.3  13.0 4.4 (2.8, 6.1)* (4.0) 749 (24.9) 1,107 (36.8) 109.8  7.6 111.7  11.5 1.9 (1.1, 2.6)* (1.7)e
120–139 680 (44.1) 793 (51.4) 129.0  5.9 124.0  11.3 5.1 (5.9, 4.3)* (4.0) 1,281 (42.6) 1,317 (43.8) 128.5  5.8 124.0  12.6 4.4 (5.1, 3.7)* (3.4)
140–160 429 (27.8) 274 (17.8) 147.5  5.9 135.0  12.4 12.6 (13.8, 11.3)* (8.5) 695 (23.1) 467 (15.5) 147.0  5.8 134.0  13.6 13.0 (14.1, 12.0)* (8.9)
> 160 172 (11.2) 66 (4.3) 170.6  12.0 148.3  18.3 22.4 (25.0, 19.7)* (13.1) 281 (9.3) 115 (3.8) 170.6  11.9 146.7  17.2 23.9 (26.1, 21.8)* (14.0)
Diastolic blood
pressure,
mm Hg
c2 ¼ 263.87, P < .001 c2 ¼ 324.93, P < .001
< 80 599 (38.8) 904 (58.6) 71.1  6.1 71.4  8.9 0.2 (0.5, 1.0) (0.3) 1,486 (49.4) 1,937 (64.4) 70.3  6.5 70.7  8.8 0.4 (0.1, 0.9) (0.6)
80–89 571 (37) 465 (30.2) 83.3  3.0 77.2  7.6 6.1 (6.8, 5.5)* (7.4) 1,001 (33.3) 855 (28.4) 83.2  2.9 77.5  8.0 5.7(6.2, 5.2)* (6.8)
90100 282 (18.3) 147 (9.5) 92.9  3.0 83.6  8.3 9.3 (10.3, 8.4)* (10.0) 406 (13.5) 174 (5.8) 92.9  3.0 82.1  8.4 10.7 (11.6, 9.9)* (11.6)
> 100 90 (5.8) 26 (1.7) 104.7  6.9 89.1  10.5 15.6 (17.7, 13.6)* (14.9) 115 (3.8) 42 (1.4) 104.4  7.7 86.8  10.2 17.5 (19.6, 15.4)* (16.8)
Total cholesterol,
mg/dL
c2 ¼ 539.01, P < .001 c2 ¼ 991.32, P < .001
< 160 484 (31%) 866 (55.4) 137.2  16.4 127.4  22.9 9.8 (11.5, 8.0)* (7.1) 473 (15.3) 946 (30.6) 142.5  14.3 137.1  23.0 5.5 (7.3, 3.6)* (3.8)e
160–199 617 (39.5) 515 (33) 178.6  11.0 156.8  22.6 21.8 (23.4, 20.1)* (12.2) 1,161 (37.6) 1,304 (42.2) 180.8  11.1 167.3  22.3 13.5 (14.7, 12.3)* (7.5)d
200–239 336 (21.5) 155 (9.9) 215.9  11.1 180.4  25.8 35.5 (38.2, 32.9)* (16.5) 950 (30.8) 650 (21) 217.5  11.3 192.7  24.6 24.8 (26.3, 23.3)* (11.4)d
240–280 103 (6.6) 20 (1.3) 255.6  12.0 203.3  32.9 52.3 (59.1, 45.5)* (20.5) 400 (13) 165 (5.3) 254.9  10.6 218.1  28.9 36.9 (39.7, 34.1)* (14.5)d
> 280 22 (1.4) 6 (0.4) 314.4  37.3 240.3  51.0 74.3 (98.3, 50.3)* (23.6) 104 (3.4) 23 (0.7) 306.3  24.6 247.9  42.2 58.4 (67.1, 49.7)* (19.1)
Low-density
lipoprotein,
mg/dL
c2 ¼ 405.43, P < .001 c2 ¼ 629.70, P < .001
< 100 565 (37.4) 844 (55.8) 78.3  16.0 70.6  19.3 7.7 (9.2, 6.3)* (9.8) 837 (27.6) 1,226 (40.4) 81.1  14.1 77.8  21.5 3.3 (4.6, 2.1)* (4.1)d
100–129 434 (28.7) 394 (26.1) 113.3  8.3 96.4  19.5 17.0 (18.8, 15.1)* (15.0) 951 (31.3) 967 (31.9) 114.6  8.7 103.9  20.2 10.7 (11.8, 9.5)* (9.3)d
130–159 276 (18.3) 131 (8.7) 141.8  8.5 114.3  21.4 27.5 (29.9, 25.0)* (19.4) 624 (20.6) 451 (14.9) 142.6  8.5 122.5  21.4 20.2 (21.8, 18.6)* (14.2)d
160189 87 (5.8) 46 (3) 171.8  7.8 136.8  26.6 35.0 (40.8, 29.1)* (20.4) 287 (9.5) 147 (4.8) 172.1  8.3 142.8  27.1 29.3 (32.3, 26.3)* (17.0)
$ 190 150 (9.9) 97 (6.4) 272.6  66.3 216.3  67.2 56.4 (64.4, 48.4)* (20.7) 337 (11.1) 245 (8.1) 274.5  68.8 236.0  74.9 38.5 (43.5, 33.5)* (14.0)d
High-density
lipoprotein,
mg/dL
c2 ¼ 148.51, P < .001 c2 ¼ 378.12, P < .001
< 40 men, < 50
women
728 (46.6) 925 (59.3) 32.9  4.8 31.6  6.5 1.3 (1.7, 0.9)* (3.8) 467 (15.1) 750 (24.3) 34.8  4.1 34.4  7.3 0.4 (1.0, 0.2)* (1.2)
4059 622 (39.8) 453 (29) 46.6  5.3 42.5  7.8 4.1 (4.6, 3.6)* (8.9) 1,581 (51.1) 1,583 (51.2) 49.1  5.5 45.5  7.7 3.6 (3.9, 3.3)* (7.3)
$ 60 211 (13.5) 183 (11.7) 90.4  26.4 81.1  26.2 9.3 (11.4, 7.3)* (10.3) 1,043 (33.7) 758 (24.5) 85.6  30.4 75.2  28.9 10.4 (11.1, 9.7)* (12.2)
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Higher Education Ethics Committee
approved the study.
Facilitator Information
The CHIP programs were conducted
by volunteer facilitators sourced pri-
marily through the Seventh-Day
Adventist Church, who had an inter-
est in positively influencing the
health of their local community. All
volunteers were required to undergo
2 days of training to learn about the
CHIP intervention and develop group
facilitation skills. There were no
educational requirements or selection
criteria for the volunteer facilitators.
The educational component of the
CHIP intervention was presented
through a set of prerecorded videos.
The role of the volunteer facilitator
was to organize the meetings and
facilitate discussion.
Description of CHIP
The CHIP intervention, founded in
1986, involved 16 group sessions
conducted in a community setting
over 30 days.5,6 Sessions were struc-
tured around a process of learning,
experiencing, and reflecting. Each
of the 16-group sessions, delivered
4 d/wk for 30 days, was approximately
1 hour in duration, with approxi-
mately half of the session involving
the viewing of a prerecorded educa-
tional video and the other half consti-
tuting group activities such as cooking
demonstrations, physical exercises,
and discussion. Participants were
educated on the etiology of chronic
disease and the benefits of positive
lifestyle choices, with particular at-
tention given to diet and physical
activity. The program advocated a pre-
dominately whole-food, plant-based
diet that is high in nutrient density
and fiber yet low in energy density.
As such, the program did not restrict
the volume of food that participants
consumed. Sessions on overcoming
barriers to change, developing emo-
tional intelligence, and providing
participants with strategies (self-
monitoring, goal setting, and problem
solving, including addressing unsup-
portive social and physical influences)
for behavior change maintenance
were also included. Use of the
supplied resources meant that the
program delivery was consistent in
each location.
The program encouraged and sup-
ported participants to move toward a
low-fat (< 15% of calories from fat),
ad libitum plant-based diet over 30
days, with emphasis on the daily
whole-foods consumption of grains,
legumes, fruits and vegetables, and
water (2–2.5 L) while limiting intake
of added sugar, sodium, and choles-
terol (40 g, 2,000 mg, and 50 mg,
respectively). In addition, the pro-
gram advocated that participants
engage in 30 minutes of moderate
physical activity daily and practice
stress management techniques. These
behaviors have previously been
shown to be efficacious for preventing
and treating chronic disease.3 Partici-
pants were deemed to have completed
the intervention if they attended a
minimum of 13 of the 16 sessions
and completed the baseline and
30-day assessments. After completion,
participants were invited to attend
ongoing monthly follow-up sessions
to reinforce lifestyle behavior changes
and build a network of support and
ongoing education. Biometric data
were not collected following the 30-
day assessment, and so evaluation of
the biometric outcomes during the
follow-up sessions is beyond the scope
of the current study.
Data Collection and Reporting
Before participating in the CHIP inter-
vention (baseline) and again at its
conclusion (postintervention), partici-
pants' height, weight, systolic blood
pressure (SBP), and DBP were taken,
and fasting (12-hour) blood samples
were collected by registered health pro-
fessionals. The same scales and sphyg-
momanometer were used for taking
measurements at baseline and again at
30 days. Blood samples were collected
by trained phlebotomists and analyzed
by local pathology laboratories for TC,
LDL, high-density lipoprotein (HDL),
TG, and FPG levels. Self-report health
conditions were also collected at base-
line but not at follow-up.
The researchers analyzed data us-
ing SPSS Statistics (version 19, IBM
Corp, Armonk, NY, 2010). The bio-
metric data was initially explored for
outliers that were beyond reasonable
physiological values, and removed.
The extent of the changes (from
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baseline to postintervention) in the
biometric measures was assessed for
males and females separately, using
paired t tests. Findings were reported
as mean  SD, because the data
were deemed to approximate
normality because of the large sample
size.19 Only participants with com-
plete pre- and postintervention data
were included for analysis of each
biometric. About 7% of men and
women (113 men and 224 women)
did not have follow-up data for any
biometric at 30 days. Furthermore,
some participants did not have
follow-up data for some risk factors;
hence, there is variation in the num-
ber (n) listed in Table 1 between the
biometrics. McNemar chi-square test
was used to determine changes in
the distribution of participants by
gender, across the various risk factor
categories. Participants' weight was
characterized using standard BMI
cut points for normal, overweight,
and obese20; BP was classified using
the Fifth Joint National Committee
for Hypertension guidelines21; and
FPG was characterized according
to conventional normal, impaired,
and diabetic levels.22 The National
Cholesterol Education Program Adult
Treatment Panel III classification sys-
tem22 was used to categorize the par-
ticipants for all risk factors except
total cholesterol, for which the Fra-
mingham risk classification23 was
used. The Framingham classification
includes 5 cholesterol categories
compared with only 3 in the National
Cholesterol Education Program Adult
Treatment Panel III classification sys-
tem, and thus allowed a more
detailed analysis of the effect of the
intervention on the highest-risk par-
ticipants. Metabolic syndrome at
baseline and after intervention was
classified according to the harmo-
nized definition.24 Participants were
deemed as having this syndrome if
they met $ 3 of the defining cri-
teria.24 P < .05 was considered signif-
icant. To reduce the Type 1 error that
can occur when simultaneous tests
are performed in a data set, Bonfer-
roni correction was applied to each
biometric separately. Because there
was a different number of risk cate-
gory comparisons for each biometric,
the correction applied was 0.05/n,
where n was the number of categories
within each biometric.
RESULTS
Of the 5,046 participants, 33.5% (n ¼
1,690) were men and 66.5% (n ¼
3,392) were women, with only 21%
reporting to be Seventh-Day Advent-
ists. The men (57.9  13.0 years)
were marginally older than the wo-
men (57.0  12.9 years) (P ¼ .027)
and more men than women reported
being smokers (2.6% vs 2.0%; P <
.001) and married (85% vs 68%;
P < .001). There were also baseline
differences in health history, with
more men commencing the inter-
vention with diagnosed heart condi-
tions such as angina (4.9% vs 2.7%;
P < .001), myocardial infarction
(6.6% vs 3.0%; P < .001), coronary
bypass (4.1% vs 1.2%; P < .001), and
diabetes (16.6% vs 12.7%; P < .001).
There were no differences for history
of stroke (2.3% vs 1.8%; P ¼ .241) or
cancer (9.0% vs 8.5%; P ¼ .556).
Men had higher baseline SBP, DBP,
TG, and FPG than women (P < .001),
whereas the women had higher base-
line TC, LDL, and HDL (P < .001)
(Table 1). There was no difference in
baseline BMI between the men and
women (P ¼ .867) (Table 1).
Both genders achieved significant
reductions in all biometrics after the
intervention, but the reductions were
greater among men than women for
all biometrics except SBP, for which
there was no difference, and HDL,
for which women had greater reduc-
tions than the men (Table 1). The TC
to HDL ratio also significantly
decreased within 30 days for all partic-
ipants combined and the reduction
was greater for men than for women
(Table 1). The proportion of men
and women classified with metabolic
syndrome at baseline decreased signif-
icantly (P < .001) at 30 days (males,
46.5% to 37.5%; females, 39.2% to
33.1%).
Stratification of risk factors showed
substantive changes in the distribu-
tion of men and women across the
various categories, with the largest re-
ductions among participants with the
highest risk classifications at baseline
(Table 2). More men than women pre-
senting with the highest category SBP
(> 160 mm Hg), DBP (> 100 mg/dL),
BMI (> 30 kg/m2), and LDL ($ 190
mg/dL) reduced their risk character-
ization at 30 days (62% vs 59%, 71%
vs 63%, 15% vs 11%, and 35% vs
27%, respectively) (Table 2). However,
in the highest risk categories for TC
(> 280 mg/dL), TG ($ 500 mg/dL),
and HDL (< 40 mg/dL), more women
than men (78% vs 73%, 79% vs 71%,
and 61% vs 27%, respectively) were
no longer in these risk categories
(Table 2). For FPG levels indicative of
diabetes (> 125 mg/dL), equal propor-
tions of men and women (43%)
reduced their risk factor categoriza-
tion in the 30 days.
An analysis of mean changes in the
various biometric categories also indi-
cated that men tended to achieve
greater improvements than the
women. For BMI, men experienced
greater decreases than women in the
baseline overweight and obese cate-
gories. For SBP and FPG, only in 1
baseline category (< 120 mm Hg and
< 110 mg/dL, respectively) was the
mean change greater for men than
women. For other risk factors, men
experienced greater mean change
than women in a number of baseline
categories: LDL, all categories, except
160–189 mg/dL; and TC, all cate-
gories, except the highest (Table 2).
DISCUSSION
Substantial reductions in selected risk
factors were achieved in 30 days using
the CHIP lifestyle intervention, with
greater reductions seen among the
men than women. In 30 days, the
majority of men in the highest risk
classifications for TC, LDL, TG, and
FPG, but only TG for women, were
able to show improvement by more
than 20%. Results from the Pritikin
program also showed that men
achieved greater reductions in chronic
disease risk factors from a lifestyle
intervention than women.25 A seem-
ingly adverse outcome of the CHIP
intervention is the reduction in HDL
among both men and women, which
has also been observed in other life-
style interventions that promote a
plant-based eating pattern.3 However,
this reduction in HDL is not consid-
ered detrimental to the risk of chronic
disease, as discussed by Kent et al.26
The reason for the difference observed
between men and women, although
not explored in this study, could be
speculated from the literature to relate
to physiological and/or behavioral
factors.
48 Kent et al Journal of Nutrition Education and Behavior  Volume 47, Number 1, 2015
In terms of physiological factors,
differences in adiposity distribution
may offer an explanation. The pro-
pensity for men to store fat in the
abdominal region, which is more
metabolically active and therefore
easier to remove than fat on the
hips and thighs, which is more com-
mon in women, may offer a physio-
logical explanation.27,28 It is well
established that central obesity
increases the risk of type 2 diabetes,
metabolic syndrome, cardiovascular
disease, dyslipidemias, and hyper-
tension.29 Other physiological expla-
nations may include the differing
hormonal profile between men and
women and the heavier weight of
men; heavier people tend to lose
more weight.30,31 Furthermore, men
are also more likely to have greater
muscle mass and therefore a higher
metabolic rate than women.32,33
In terms of the other metabolic
risk factors, differences in food pref-
erences and the amount of food eaten
by men and women may offer physi-
ological explanations for the
observed differences at 30 days. Diets
high in whole-plant foods and low in
red and processed meat may provide
benefits for the prevention and treat-
ment of not only obesity but other
chronic health problems, including
type 2 diabetes and cardiovascular
disease.34 Plant foods are rich in fiber
and a range of phytochemicals and
antioxidants, which are believed to
confer these health benefits.35
Because women tend to eat more fruit
and vegetables than do men and
men's diets tend to be higher in red
and processed meats and lower in fi-
ber,35,36 there is greater scope for
changes in men's diets to include
more plant foods. However, this
study did not collect information on
dietary intake to examine this more
closely. The benefit of the greater
muscle mass of men also means they
have a greater requirement for dietary
energy than women.37 Consequently,
the higher intake of health-
promoting plant foods required to
meet the energy demands of men,
together with increases in physical ac-
tivity, as promoted by the CHIP inter-
vention, are therefore expected to
more quickly ameliorate the adverse
effect of a previously poor lifestyle
compared with the lower intakes
required by women.
Women tend to participate in com-
mercial weight loss programs such as
Weight Watchers or be treated for
weight problems by a primary care
provider more so than men.30 Indeed,
women are more likely to be aware of
or concerned that they are over-
weight.30,38 Certainly, two thirds of
the CHIP participants were women.
The way men and women engage
with lifestyle interventions may offer
a behavioral explanation for why
men might achieve better outcomes.
Men seem to approach making the
commitment to change differently
from women.39 Men are more in-
clined to commit to a program if the
benefits outweigh the costs.39 Indeed,
once men have made a decision, they
are more likely to complete a program
that is prescriptive40 and achieve their
goals,41 particularly if advised by a
health professional.30 On the other
hand, women are inclined to commit
to interventions for social reasons
(trust, interaction, and obligations
to significant others).39 However,
whereas women tend to have higher
expectations and be more eager to
initially change behavior than
men,39 they are also inclined to be
more easily disappointed and risk
dropping out before reaching their
target.42 Therefore, although the liter-
ature suggests men seem to take
longer to engage with the program,
there is anecdotal evidence that once
they have assessed and evaluated the
evidence and made a commitment,
they appear to achieve better results
in a shorter time than women (Profes-
sor G. Egger, Founder of Gut Busters,
personal communication). However,
this could not be explored in this
study because information on com-
mitment was not collected. The
difference in men's and women's
engagement in the CHIP intervention
program needs to be explored in
further research.
Having supportive relationships
may be a behavioral factor that ex-
plains the greater effect on men than
women observed in this study. Men
who are married are less likely to
engage in unhealthy, high-risk behav-
iors and therefore experience better
health through the influence of their
wives.43 In the current study, there is
anecdotal evidence also supported
by the literature44 that men are per-
suaded to attend CHIP with their
wives, which according to the
stages of change theory suggests that
they enter the program as pre-
contemplators, whereas women enter
at the preparation stage.45 The suppo-
sition that the married men who at-
tended the CHIP intervention with
their spouse benefited from the
ensuing household changes made by
the women is supported by the litera-
ture.46 Indeed, an intervention deliv-
ered in a group setting offers the
social support needed to foster new
social norms and accountability.
Group programs have been shown to
be more effective for achieving weight
loss than individual programs, even
for those who claim to prefer individ-
ual programs.47
Other factors relating to program
content and structure may have
contributed to the outcomes observed
in this study. One may be the inten-
siveness of the CHIP intervention.
Other studies have shown a dose
response between intervention inten-
sity and health outcomes.3,48 Further
research is required to determine
the most efficacious dosages of
lifestyle interventions with regard to
the number of sessions, program
duration, and type and magnitude of
lifestyle modifications targeted for
men and women. Other factors may
be the strong educative component
and repeated health risk assessments.
These are believed to increase partici-
pants' health related self-efficacy and
perceived control. Future research
should explore self-efficacy/perceived
behavioral control among men and
women participating in CHIP result-
ing from the increased knowledge
that comes from the educational
videos.
Study Limitations and Strengths
In this study, a greater proportion of
men entered the program with previ-
ously diagnosed health conditions,
which may have contributed to the
higher baseline risk factor levels of
men compared with women.
However, < 5% of each gender
entered the program with cardiovas-
cular disease conditions, and so it is
unlikely that baseline health history
would have had a major impact on
the outcomes of the intervention.
Another limitation of this study is
missing data. However, it is not
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expected that the missing data would
have attenuated the outcomes re-
ported in this study, because the pro-
portion was similar (# 7%) for both
men and women.
The ability of self-selected partici-
pants to pay the program fee could
have led to selection bias of persons
with economic advantage over those
who could not afford the fee, or of per-
sons interested in health compared
with those not interested in making
changes and therefore not willing to
pay. Because the interventions are
sourced primarily through the
Seventh-Day Adventist church, this
may have biased the selection process
and therefore the outcomes. However,
because only one-fifth of participants
reported being Seventh-Day Advent-
ists, it is not likely that motivation to
participate could be attributed to
membership of this health-conscious
religious denomination. The general-
izability of the findings to less moti-
vated populations and with differing
baseline health characteristics, eg,
biometrics and smoking status needs
to be determined.
Information on fat distribution,
particularly android fat; compliance
measures, particularly for dietary
intake and physical activity; socioeco-
nomic factors such as social class and
ethnicity, and who the participant at-
tended the program with; and readi-
ness to change are important factors
that may have contributed to the
gender difference and are lacking in
this study. Lack of information to
align risk factors with behaviors is a
limitation of this study. Future studies
will gather valid measures of psycho-
social factors and the various lifestyle
changes made by participants during
the CHIP program to elucidate their
contribution to the results achieved.
Despite these limitations, the re-
sults of this study, which show the
value of CHIP to lower risk factors,
are noteworthy given the size of the
sample and the large reductions
observed, particularly among individ-
uals commencing the program with
the greatest risk. Risk factor character-
ization of all biometrics was reduced
to at least the next lower level for
both men and women, but more so
for men, with some participants
reducing 2 or 3 levels, particularly if
they were in the higher risk categories
at baseline. Therefore, reporting the
mean change at each risk level actu-
ally underestimated the actual change
in this study as participants reduced
their risk characterization.
Notwithstanding the greater reduc-
tions among men, women achieved
substantial risk reductions for most
biometrics and the intervention ap-
pears to be beneficial for both genders.
More than 60% of men and women
with highest baseline risk levels for
SBP, DBP, TC, and TG reduced their
risk characterization after the 30-day
intervention. In addition, almost
half of men and women characterized
with diabetes and high baseline levels
of LDL reduced these characteriza-
tions. These improvements translated
to a 19.4% reduction in men and a
15.7% reduction in women who
were characterized with metabolic
syndrome at baseline. Furthermore,
the changes in TC and LDL levels
compare favorably with those
achieved by pharmaceutical interven-
tions involving statins49 but without
the risk, and are much greater than
those expected from dietary interven-
tions aimed at lowering blood lipids.50
The strength of the CHIP interven-
tion is the strong education compo-
nent that focuses on the etiology of
chronic disease and the benefits of
positive lifestyle choices, with parti-
cular attention given to diet, physical
activity, sleep, and stress; overcom-
ing barriers; maintaining behavior
change; environmental influences on
lifestyle practices; mental and emo-
tional health; and self-worth and per-
sonal flourishing.
IMPLICATIONS FOR
RESEARCH AND
PRACTICE
The educationally centered CHIP life-
style intervention is effective at
reducing selected chronic disease fac-
tors in 30 days for both men and
women, but especially for men. How-
ever, it appears that male and female
participants react differently to these
interventions. Although this study
did not examine the physiological
and behavioral reasons for this differ-
ence, the literature suggests that life-
style interventions targeting women
should be delivered in a socially inter-
active group setting. For men, the
literature suggests that interventions
should involve a prescriptive regime.
Both men and women appear to
benefit from programs that focus on
an eating regime that is high in mini-
mally processed, whole, plant foods,
because this is nutrient dense and sati-
ating, yet low in calories. This eating
regime not only benefits weight loss
but improves other chronic disease
risk factors. In addition, lifestyle inter-
ventions should incorporate physical
activity, including strength training
routines to build lean muscle
mass and increase metabolic rate in
programs that include women.
Interventions delivered through an
entertaining, evidence-based educa-
tive video in an interactive setting,
with regular health risk assessments,
appear to be efficacious in fostering
behavior change by developing
perceived control and self-efficacy.
As lifestyle interventions such as
CHIP continue to expand globally,
more research needs to be undertaken
to establish how best to meet the
different needs of male and female
participants.
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